Prostatic Artery Embolization: Indications, Preparation, Techniques, Imaging Evaluation, Reporting, and Complications.
Ubenicio Silveira DiasMaurício Ruettimann Liberato de MouraPublio Cesar Cavalcante VianaAndré Moreira de AssisAntônio Sérgio Zanfred MarcelinoAirton Mota MoreiraClaudia da Costa LeiteGiovanni Guido CerriFrancisco César CarnevaleNatally HorvatPublished in: Radiographics : a review publication of the Radiological Society of North America, Inc (2021)
Benign prostatic hyperplasia (BPH) is a noncancerous growth of the transitional zone of the prostate, which surrounds the prostatic urethra. Consequently, it can cause lower urinary tract symptoms (LUTS) and bladder outlet obstruction symptoms that may substantially reduce a patient's quality of life. Several treatments are available for BPH, including medications such as α-blockers and 5α-reductase inhibitors and surgical options including transurethral resection of the prostate and prostatectomy. Recently, prostatic artery embolization (PAE) has emerged as a minimally invasive treatment option for selected men with BPH and moderate to severe LUTS. Adequate pre- and postprocedural evaluations with clinical examinations and questionnaires, laboratory tests, and urodynamic and imaging examinations (particularly US, MRI, and CT) are of key importance to achieve successful treatment. Considering that the use of PAE has been increasing in tertiary hospital facilities, radiologists and interventional radiologists should be aware of the main technical concepts of PAE and the key features to address in imaging reports in pre- and postprocedural settings. An invited commentary by Lopera is available online. Online supplemental material is available for this article. ©RSNA, 2021.
Keyphrases
- benign prostatic hyperplasia
- lower urinary tract symptoms
- high resolution
- minimally invasive
- magnetic resonance imaging
- artificial intelligence
- contrast enhanced
- health information
- emergency department
- computed tomography
- adverse drug
- case report
- early onset
- risk factors
- mass spectrometry
- physical activity
- middle aged
- angiotensin converting enzyme
- combination therapy
- diffusion weighted imaging
- replacement therapy